Danaher Corporation $DHR Shares Acquired by Sivia Capital Partners LLC

Sivia Capital Partners LLC lifted its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 437.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 8,642 shares of the conglomerate’s stock after purchasing an additional 7,035 shares during the period. Sivia Capital Partners LLC’s holdings in Danaher were worth $1,978,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Enterprise Financial Services Corp increased its holdings in Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after purchasing an additional 46 shares in the last quarter. Kennebec Savings Bank increased its holdings in Danaher by 1.4% in the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after purchasing an additional 46 shares in the last quarter. Revolve Wealth Partners LLC increased its holdings in Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after purchasing an additional 47 shares in the last quarter. High Note Wealth LLC increased its holdings in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. Finally, Kestra Private Wealth Services LLC increased its holdings in Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $178.40 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company’s 50-day simple moving average is $181.40 and its 200-day simple moving average is $206.59. The stock has a market capitalization of $126.26 billion, a price-to-earnings ratio of 34.51, a PEG ratio of 2.35 and a beta of 0.81.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the company posted $1.88 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Analyst Ratings Changes

DHR has been the subject of several recent research reports. Robert W. Baird lowered their price target on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a report on Friday, April 17th. Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. Wells Fargo & Company lowered their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley lowered their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Evercore raised their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Twenty research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $235.14.

Check Out Our Latest Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.